VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

41 hedge funds and large institutions have $48.7M invested in Viracta Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
-4
Holders Change %
-8.89%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
10
Reduced
9
Closed
9
Calls
$925K
Puts
$51K
Net Calls
+$874K
Net Calls Change
+$118K